Natural course and mid- to long-term outcomes of conservatively managed spontaneous isolated celiac artery...

Spontaneous isolated celiac artery dissection (SICAD) is a rare condition with an unclear natural history and no management consensus. This study evaluated mid- to long-term outcomes of conservatively managed SICAD.

This single-center, retrospective cohort study identified patients with SICAD from January 2011 to December 2022 in the institutional electronic health record. Demographics, comorbidities, radiographic features, management, and outcomes were reviewed. Clinical end points were symptomatic remission, significant organ malperfusion, rupture, and secondary intervention. Radiographic end points included dissection remodeling (ie, shortened dissection length or increased true lumen diameter), celiac aneurysm incidence, and aneurysm diameter growth among <1.5-cm, 1.5- to 1.9-cm, and ≥2.0-cm size categories. End points were stratified by symptomatic vs incidental presentation.

Forty-nine patients with SICAD were identified. Eighty percent were male, and 57% had hypertension. Extraceliac aneurysms were present in 25%, including 12% with aortic aneurysms. Forty-nine percent of SICADs were symptomatic on presentation, and 51% were discovered incidentally. Patients with incidental SICAD were older than symptomatic patients (62 ± 15 years vs 54 ± 8 years, respectively; P = .02), but had similar comorbidities. Ninety-two percent of symptomatic patients experienced complete symptom resolution without operative intervention by the earliest follow-up (182 ± 386 days). No incidental cases developed symptoms over a mean of 3.9 ± 3.5 years. No significant organ malperfusion, rupture, or secondary intervention occurred in this series. Symptomatic SICAD was more likely to undergo remodeling than incidental SICAD (P = .02) over an average of 3.3 ± 3.7 years. Thirty-two percent of symptomatic cases had partial remodeling, and 37% had no residual dissection. Seventy-one percent of incidental dissections remained stable without remodeling. Celiac thrombus on initial imaging predicted remodeling (P = .003). Baseline antihypertensive (P = .006) and antiplatelet use (P = .047) were associated with remodeling in symptomatic patients only. Aneurysmal degeneration was noted in 46% of all presenting lesions; none were ≥2.0 cm in maximal diameter. Incidental cases presented with more aneurysmal dilatation than symptomatic cases (59% vs 32%; P < .001). No celiac aneurysms at presentation grew over an average of 4.8 ± 4.0 years. Forty percent and 13% of incidental and symptomatic cases without initial celiac aneurysms, respectively, developed incident aneurysms by a mean follow-up of 2.0 ± 3.0 years (P = .3).

Conservative management of uncomplicated SICAD yielded excellent clinical outcomes, even with incomplete remodeling and aneurysmal degeneration, which were common, albeit largely benign. Patients may warrant screening for aneurysms beyond the celiac axis. Antihypertensive and antiplatelet therapy for ≥3 to 6 months may promote remodeling until dissection stabilization.